← Meclofenoxate

Patient counseling sheet

Print-ready and generated without storing patient details.

AfyaIndex · counseling handout

Meclofenoxate

Therapeutic agent (verify pharmacological class)

Prepared 04 Nov 2026

What it is used for

Mental deterioration; mental fatigue and inability to concentrate, disturbed memory and mood, intellectual impairment and behavioral changes. Neurological symptoms; transient neurological attacks, paresis of face and limbs, visual disturbance, vertigo, tinnitus, motor, sensory aphasia, cerebral aging, and cerebral atherosclerosis.

Warnings

Obtain allergy and medication history. Adjust for renal/hepatic impairment, pregnancy, lactation, extremes of age and interacting drugs. Use the lowest effective dose for the shortest appropriate duration. Monitor for expected class adverse effects.

Possible side effects

Adverse reactions vary by agent. Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes). Report suspected ADRs via national pharmacovigilance channels.

Storage

Store as labelled. Keep out of reach of children.

No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.

AfyaIndex dataset coverage